Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
November 25, 2022 16:50 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 25, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Announces Completion of Corporate Name Change
November 14, 2022 09:02 ET
|
Lifecore Biomedical, Inc.
Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol “LFCR” Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com ...
Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022
November 10, 2022 08:00 ET
|
Landec Corporation
CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore...
Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14
November 01, 2022 08:00 ET
|
Landec Corporation
CHASKA, Minn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”) today announced that it expects to effect its previously announced corporate name...
Landec Corporation Reports First Quarter Fiscal Year 2023 Results
October 06, 2022 07:15 ET
|
Landec Corporation
Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus the prior year periodLifecore segment EBITDA increased 8.1% to $2.5 million in fiscal 2023 first quarter...
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
September 28, 2022 16:05 ET
|
Landec Corporation
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its...
Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT
September 21, 2022 08:00 ET
|
Landec Corporation
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its...
Landec Corp. Receives Notice from Nasdaq Regarding Delayed Annual Report
September 09, 2022 16:30 ET
|
Landec Corporation
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Landec Corp. (NASDAQ: LNDC) (the “Company”) announced today that it received a notice (“Notice”) on September 2, 2022 from the...
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
August 10, 2022 16:07 ET
|
Landec Corporation
Recently announced intent to rename and rebrand to Lifecore Biomedical, along with leadership and Board changes Lifecore segment revenues increased 6.9% to $27.6 million in fiscal fourth quarter,...
Landec Corporation Announces Intention to Become Lifecore Biomedical
August 10, 2022 16:04 ET
|
Landec Corporation
Landec expected to rename and rebrand to Lifecore Biomedical and update Nasdaq ticker symbol Names new CEO Announces future changes to its Board of Directors SANTA MARIA, Calif. and MINNEAPOLIS,...